Boston Scientific Corporation (BSX) Stock

Healthcare · Medical Devices · Member of S&P 500

Boston Scientific Corporation (BSX) closed at USD 43.00 on 2026-10-14, a change of -57.4 % over the past year, with a market capitalization of USD 63.97B.

Boston Scientific Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Boston Scientific Corporation key figures

Previous close

USD 43.00 (2026-10-14)

1-year change

-57.4 %

Market cap

USD 63.97B

Enterprise value

USD 76.3B

P/E ratio (trailing)

17.52

P/E ratio (forward)

13.07

EPS (trailing)

2.52

EPS (forward)

3.38

PEG ratio

0.60

Price to book

2.56

Revenue growth

7.5 %

Earnings growth

15.1 %

Dividend per share (trailing)

0.00

Short ratio

1.99

Employees

59,000

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Boston Scientific Corporation and compare it with other stocks.